Vestand Inc. 8-K

What Happened

• Vestand Inc. (VSTD) announced on its May 26, 2026 Form 8‑K that Nasdaq issued a Staff Delisting Determination on May 19, 2026 because the company has not filed its Form 10‑Q for the period ended September 30, 2025, its Form 10‑K for the fiscal year ended December 31, 2025, and its Form 10‑Q for the period ended March 31, 2026 (the “Delinquent Reports”).
• The company submitted a hearing request on May 22, 2026 to appeal Nasdaq’s determination; that request automatically stays any suspension of trading for 15 days and the company also asked Nasdaq to further stay the determination pending the hearing. Nasdaq had previously granted exceptions to regain compliance through May 18, 2026 based on submissions from January 23 and May 4, 2026.
• Vestand said it is working to prepare and file the Delinquent Reports but warned there is no assurance the reports will be filed before a hearing, that a stay will be granted, or that Nasdaq will accept any plan to regain compliance.

Key Details

• Staff Delisting Determination date: May 19, 2026. Hearing request filed: May 22, 2026. Press release attached dated May 26, 2026.
• Delinquent filings: Q3 2025 Form 10‑Q (ended Sept. 30, 2025), 2025 Form 10‑K (fiscal year ended Dec. 31, 2025), Q1 2026 Form 10‑Q (ended Mar. 31, 2026).
• Automatic stay of suspension: 15 days from hearing request; hearings are typically scheduled ~30–45 days after the request.
• Possible outcome if stay/extension denied: delisting from Nasdaq; shares may become eligible to trade on the over‑the‑counter (OTC) market (not guaranteed).

Why It Matters

• For investors, a Nasdaq delisting would likely reduce liquidity and could make buying or selling Vestand shares more difficult and potentially depress the market price. Trading on OTC markets, if it occurs, generally involves less transparency and lower trading volume.
• The company’s ability to remain listed depends on timely filing of required SEC reports and on the outcome of its appeal and any extension requests to Nasdaq. Vestand’s 8‑K explicitly cautions there is no assurance it can resolve these issues before a hearing or that Nasdaq will accept its plan to regain compliance.